CUMULATIVE SAFETY ASSESSMENT OF THE TAKEDA TETRAVALENT DENGUE VACCINE CANDIDATE IN PARTICIPANTS 4 TO 60 YEARS OLD

被引：0
|
作者：
Patel, Sanjay S. [1 ]
Rauscher, Martina [1 ]
Peng, Hang [2 ]
机构：
[1] Takeda Pharmaceut, Zurich, Switzerland
[2] Takeda Pharmaceut Int Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2021年 / 105卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1290
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [31] Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study
    Saez-Llorens, Xavier
    Tricou, Vianney
    Yu, Delia
    Rivera, Luis
    Tuboi, Suely
    Garbes, Pedro
    Borkowski, Astrid
    Wallace, Derek
    LANCET INFECTIOUS DISEASES, 2017, 17 (06): : 615 - 625
  • [32] Safety Evaluation of Chimeric Langat/Dengue 4 Flavivirus, a Live Vaccine Candidate Against Tick-Borne Encephalitis
    Pripuzova, Natalia S.
    Tereshkina, Natalia V.
    Gmyl, Larissa V.
    Dzhivanyan, Tatiana I.
    Rumyantsev, Alexander A.
    Romanova, Lidiya Iu.
    Mustafina, Aida N.
    Lashkevich, Vasilii A.
    Karganova, Galina G.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (10) : 1777 - 1785
  • [33] Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial
    Biswal, Shibadas
    Borja-Tabora, Charissa
    Martinez Vargas, Luis
    Velasquez, Hector
    Theresa Alera, Maria
    Sierra, Victor
    Johana Rodriguez-Arenales, Edith
    Yu, Delia
    Wickramasinghe, Pujitha
    Moreira, Edson Duarte, Jr.
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Kosalaraksa, Pope
    Espinoza, Felix
    Lopez-Medina, Eduardo
    Bravo, Lulu
    Tuboi, Suely
    Hutagalung, Yanee
    Garbes, Pedro
    Escudero, Ian
    Rauscher, Martina
    Bizjajeva, Svetlana
    LeFevre, Inge
    Borkowski, Astrid
    Saez-Llorens, Xavier
    Wallace, Derek
    LANCET, 2020, 395 (10234): : 1423 - 1433
  • [34] SAFETY AND IMMUNOGENICITY OF ACELLULAR PERTUSSIS-VACCINE, COMBINED WITH DIPHTHERIA AND TETANUS AS THE JAPANESE COMMERCIAL TAKEDA VACCINE, COMPARED WITH THE TAKEDA ACELLULAR PERTUSSIS COMPONENT COMBINED WITH LEDERLES DIPHTHERIA AND TETANUS TOXOIDS IN 2-MONTH-OLD, 4-MONTH-OLD AND 6-MONTH-OLD INFANTS
    WATSON, B
    CAWEIN, A
    MCKEE, BL
    HACKELL, JG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (11) : 930 - 935
  • [35] Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: A randomized, placebo-controlled, Phase III study
    Hss, Amar-Singh
    Koh, Mia-Tuang
    Tan, Kah Kee
    Chan, Lee Gaik
    Zhou, Lynn
    Bouckenooghe, Alain
    Crevat, Denis
    Hutagalung, Yanee
    VACCINE, 2013, 31 (49) : 5814 - 5821
  • [36] Chimeric yellow fever-dengue tetravalent vaccine (ChimeriVax™-DEN1-4):: Precilnical safety and efficacy in non-human primates
    Draper, K
    Fournier, C
    Levenbook, I
    Myers, G
    Guirakhoo, F
    Monath, TP
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A85 - A85
  • [37] STUDY OF THE SAFETY AND THE IMMUNOGENICITY OF INACTIVATED ANTI-HEPATITIS-A VACCINE IN 30 HEALTHY-CHILDREN 2 YEARS OLD TO 4 YEARS OLD
    DOSSEH, B
    PARENT, D
    LEHNER, V
    AUFRERE, A
    BOUDJADJA, A
    MEDECINE ET MALADIES INFECTIEUSES, 1993, 23 (05): : 385 - 387
  • [38] Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2-17 years: systematic review and meta-analysis
    Rosa, Bruno Rodrigues
    Ledo Alves da Cunha, Antonio Jose
    Medronho, Roberto de Andrade
    BMJ OPEN, 2019, 9 (03):
  • [39] SAFETY AND IMMUNOGENICITY OF DIFFERENT FORMULATIONS OF A TETRAVALENT DENGUE PURIFIED INACTIVATED VACCINE (DPIV) IN HEALTHY ADULTS FROM PUERTO RICO THROUGH THREE YEARS OF FOLLOW-UP
    Koren, Michael
    Diaz, Clemente
    Lin, Leyi
    Martinez, Luis
    Eckels, Kenneth
    Campos, Maribel
    Jarman, Richard
    De La Barrera, Rafael
    Lepine, Edith
    Febo, Irma
    Innis, Bruce
    Vaughn, David
    Wilson, Todd
    Schmidt, Alexander
    Paris, Robert
    Thomas, Stephen
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 241 - 241
  • [40] IMMUNOGENICITY AND SAFETY OF TAKEDA'S DENGUE VACCINE CANDIDATE IN CHILDREN AND ADOLESCENTS AGED 2-17 YEARS FROM PANAMA, THE DOMINICAN REPUBLIC AND THE PHILIPPINES: 18-MONTH RESULTS FROM A PHASE 2 RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Tricou, Vianney
    Saez-Llorens, Xavier
    Yu, Delia
    Rivera, Luis
    Borkowski, Astrid
    Wallace, Derek
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 252 - 253
12345